Inability of Viral Superantigens to Induce CD4-mediated Islet Transplant Rejection
DOI:
https://doi.org/10.29173/eureka10296Abstract
Superantigens have the ability to bypass the specific interactions of the MHC class II and T-cell receptor by binding outside of the peptide binding region and onto the Vβ chain. This ability allows superantigens to stimulate a wide array of T-cell populations, irrespective of T-cell receptor (TCR) specificity. Research on bacterial and viral superantigens have demonstrated various outcomes ranging from superantigen dependent cellular cytoxicity (SDCC), rheumatoid arthritis, to superantigen stimulated T-cell clonal deletion and anergy. Due to its ability to proliferate a large population of T-cells, this paper asks whether superantigens have a role in islet transplant rejection. We used transgenic Vβ6 TCR mice specific for male ‘H-Y’ antigen as recipients to islet transplants. Donors comprised mice expressing endogenous superantigen specific for the Vβ6 chain. Transplantation of these donor islets did not induce rejection. Recipients were also primed with ‘H-Y’ antigen to induce a CD4 effector memory T-cell population prior to islet transplantation. Even with primed recipients, donor islet transplants did not induce rejection by recipient transgenic mice.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
By signing the Eureka publication agreement, authors agree to the following:
- The work has not been previously published in any format;
- Eureka is granted the royalty-free right to publish and disseminate the work in current and future formats;
- The work will be published in Eureka under a Creative Commons license. Eureka encourages authors to publish the work under a Creative Commons Attribution 4.0 International license (CC BY 4.0) that allows others to distribute, tweak, and build upon the work, even commercially, as long as they credit the Author(s) for the original creation.
Authors may however choose to have their work distributed under any of the Creative Commons licenses currently available by specifying their preferred license in the publication agreement. A description of the Creative Commons licenses is available here: https://creativecommons.org/licenses/
- Authors retain their copyright, including the right to subsequently publish or disseminate their work elsewhere, provided that they make reasonable efforts to ensure that the publication in Eureka is acknowledged.
- Authors agree to determine, prior to publication, whether it is necessary to obtain permissions from any third party who hold rights with respect to any photographs, illustrations, drawings, text, or any other material (“third party work”) to be published in connection with your work. Copyright permission will not be necessary if the use is determined to be fair dealing, if the work is in the public domain, or if the rights-holder has granted a Creative Commons or similar license.
- All co-authors and investigators (e.g. faculty supervisors) with claims to the intellectual property have read and signed the agreement, thereby providing their consent for the submission to be published in Eureka.
Unless otherwise specified, authors guarantee that all parts of the submission are the author’s original work. Submissions containing evidence of plagiarism will not be eligible for publication.